Contact
Adcendo ApS
Ole Maaloees Vej 3
2200 Copenhagen N
DENMARK
CVR DK38780093
For all inquiries, please contact Adcendo via e-mail: info@adcendo.com
For media inquiries:
Optimum Strategic Communications
Mary Clark, Manel Mateus, Eleanor Cooper
Tel: +44 (0) 203 882 9621
E-mail: adcendo@optimumcomms.com
Investor Contact:
Michael Pehl, CEO
Tel: +45 31541824
Email: Michael.Pehl@adcendo.com
About Adcendo
Adcendo was founded in 2017 as a spin-out from The University of Copenhagen and Rigshospitalet. The scientific founders, Niels Behrendt, Lars Engelholm and Christoffer Nielsen from The Finsen Laboratory, had just recently published proof-of-concept for uPARAP-directed ADCs, where a first-generation, anti-uPARAP ADC was shown to effectively mediate a curative outcome in a CDX model. Ensuring that these findings were investigated further by creating a spin-out company for this purpose, was a natural next step
